CORONAVIRUS/COVID-19 antiviral drugs now available to patients in home quarantine
Taipei, May 5 (CNA) COVID-19 patients in home quarantine are now able to receive the antiviral medications Paxlovid and molnupiravir, after 20,000 courses of the drugs were delivered to key pharmacies around the country, the Central Epidemic Command Center (CECC) said Thursday.
The drugs were previously only available to patients in hospitals, government quarantine centers or designated hotels.
Paxlovid can be prescribed to treat mild-to-moderate COVID-19 within five days of the onset of symptoms for adults and children aged 12 and above with a minimum weight of 40 kilograms, if they are assessed to be at high risk of developing severe illness.
Meanwhile, molnupiravir can be prescribed to treat patients aged 18 or above with mild to moderate COVID-19 within five days of the onset of symptoms if they are assessed to be at high risk of developing severe illness and cannot use other types of COVID-19 medication.
According to Lo Yi-chun (羅一鈞), deputy head of the CECC's medical response division, COVID-19 patients are considered high-risk if they are 65 years old and above, current or former smokers, have a body mass index (BMI) above 29, or certain disabilities.
The list also includes those who have cancer, diabetes, chronic kidney disease, cardiovascular diseases (excluding high blood pressure), chronic lung diseases, tuberculosis, chronic liver diseases, dementia, mental illnesses such as schizophrenia, and autoimmune diseases, Lo said.
COVID-19 patients quarantining at home can arrange a doctor's appointment via the EUCARE (健康益友) app (Google Android / Apple iOS) or local health authorities, where they will be evaluated to determine their eligibility to receive the antiviral drugs, Lo said.
After getting a prescription, patients can arrange for pharmacies to deliver the medication or have someone get it for them, either via the EUCARE app or by contacting a pharmacy directly.
Patients can see which pharmacies are participating in the program on the Federation of Taiwan Pharmacist Association website, Lo added.
Currently, Taiwan has used only 947 courses of Paxlovid and 468 courses of molnupiravir, out of the 370,000 and 5,000 courses that have been delivered, respectively, Lo said.
Update (May 7)
- Fourth round of rapid test rationing plan to start Aug. 15The fourth round of the government's COVID-19 rapid test kits rationing scheme will begin on Aug. 15, with every holder of a National Health Insurance (NHI) card or Alien ...08/12/2022 07:24 PM
- Taiwan reports 21,989 new COVID-19 cases, 31 deathsTaiwan on Friday reported 21,989 new cases of COVID-19 and 31 deaths from the disease, according to the Central Epidemic Command Center (CECC).08/12/2022 03:16 PM
- Taiwan reports 22,909 new COVID-19 cases, 44 deathsTaiwan on Thursday reported 22,909 new cases of COVID-19, all but 259 of which were domestic infections, as well as 44 deaths from the disease, according to the Central Epidemic ...08/11/2022 03:15 PM
Household income inequality in 2021 highest in 10 years: DGBAS08/12/2022 09:32 PM
Disposable income hike expected to reduce income tax next year08/12/2022 09:20 PM
DPP's Taoyuan mayoral candidate pulls out over thesis plagiarism (update)08/12/2022 08:35 PM
Taiwan cuts GDP growth forecast for 2022 to 3.76%08/12/2022 07:45 PM
Fourth round of rapid test rationing plan to start Aug. 1508/12/2022 07:24 PM